[Mechanism and treatment of cancer metastasis to bone]

Toshiyuki Yoneda1

  • 1Department of Biochemistry, Osaka University Graduate School of Dentistry.

Clinical Calcium
|July 5, 2005
PubMed

Insights

Cancer cells preferentially metastasize to bone by altering the bone microenvironment. Targeting this process with bisphosphonates can inhibit bone metastases development and progression.

Area of Science:

  • Oncology
  • Bone Biology
  • Cancer Metastasis

Context:

  • Bone is a common site for metastasis from breast, prostate, and lung cancers.
  • Cancer cells interact with the bone microenvironment to facilitate their colonization and growth.
  • The precise molecular mechanisms driving bone tropism are not fully understood.

Purpose:

  • To elucidate the mechanisms by which cancer cells establish bone metastases.
  • To highlight the role of cancer cell-induced bone resorption in metastasis.
  • To propose bisphosphonates as a therapeutic strategy to disrupt this process.

Summary:

  • Cancer cells modulate the bone microenvironment, promoting their survival and proliferation.
  • Cancer cells produce cytokines that increase osteoclastic bone resorption.
  • This resorption releases growth factors, further supporting cancer cell colonization and promoting bone metastasis development.

Impact:

  • Understanding the cancer cell-bone crosstalk is crucial for developing effective treatments.
  • Bisphosphonates can disrupt the cycle of bone resorption and cancer cell growth.
  • Targeting bone metastases can improve patient outcomes for common cancers.

Related Concept Videos

Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...